Literature DB >> 7684323

The role of 5-hydroxytryptamine (5-HT) receptor subtypes and plasticity in the 5-HT systems in the regulation of nociceptive sensitivity.

P K Eide1, K Hole.   

Abstract

This review shows that the role of 5-hydroxytryptamine (5-HT) in the regulation of nociception depends on the 5-HT receptor subtypes involved and on long-term functional changes in the 5-HT receptors. Stimulation of the 5-HT1 receptors, as well as of the 5-HT2 and 5-HT3 receptors, may reduce nociceptive sensitivity. In addition, activation of 5-HT2 and 5-HT3 receptors may also enhance nociceptive sensitivity. Up- or down-regulation of the 5-HT receptors may result in long-lasting changes, plasticity, in the 5-HT systems. Lesioning of 5-HT neurons induces denervation supersensitivity to 5-HT, and prolonged stimulation of 5-HT receptors may produce subsensitivity to 5-HT. In the spinal cord denervation supersensitivity to 5-HT may depend on reduced release of substance P (SP). An increase in the release of SP, on the other hand, may reduce the effects of 5-HT receptor activation. Long-term treatment with antidepressants which are used in clinical pain therapy appears to up-regulate the 5-HT1 receptors and to down-regulate the 5-HT2 receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684323     DOI: 10.1046/j.1468-2982.1993.1302075.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  23 in total

Review 1.  Serotonergic agents in the management of cluster headache.

Authors:  Giorgio Lambru; Manjit Matharu
Journal:  Curr Pain Headache Rep       Date:  2011-04

2.  Serotonin 5-HT2 receptors induce a long-lasting facilitation of spinal reflexes independent of ionotropic receptor activity.

Authors:  Barbara L Shay; Michael Sawchuk; David W Machacek; Shawn Hochman
Journal:  J Neurophysiol       Date:  2005-07-20       Impact factor: 2.714

3.  Pronociceptive effect of 5-HT(1A) receptor agonist on visceral pain involves spinal N-methyl-D-aspartate (NMDA) receptor.

Authors:  A Mickle; P Kannampalli; M Bruckert; A Miranda; B Banerjee; J N Sengupta
Journal:  Neuroscience       Date:  2012-05-22       Impact factor: 3.590

4.  Pharmacological characterization of serotonin receptor subtypes modulating primary afferent input to deep dorsal horn neurons in the neonatal rat.

Authors:  S M Garraway; S Hochman
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

Review 5.  Serotonergic transmission after spinal cord injury.

Authors:  Raffaele Nardone; Yvonne Höller; Aljoscha Thomschewski; Peter Höller; Piergiorgio Lochner; Stefan Golaszewski; Francesco Brigo; Eugen Trinka
Journal:  J Neural Transm (Vienna)       Date:  2014-05-28       Impact factor: 3.575

6.  An altered spinal serotonergic system contributes to increased thermal nociception in an animal model of depression.

Authors:  Antonio Rodríguez-Gaztelumendi; María Luisa Rojo; Angel Pazos; Alvaro Díaz
Journal:  Exp Brain Res       Date:  2014-03-01       Impact factor: 1.972

7.  Absence of thermal hyperalgesia in serotonin transporter-deficient mice.

Authors:  Carola Vogel; Rainald Mössner; Manfred Gerlach; Thoralf Heinemann; Dennis L Murphy; Peter Riederer; Klaus-Peter Lesch; Claudia Sommer
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

8.  Serotoninergic-mediated inhibition of substance P sensitive deep dorsal horn neurons: a combined electrophysiological and morphological study in vitro.

Authors:  Matthew A Worsley; Andrew J Todd; Anne E King
Journal:  Exp Brain Res       Date:  2004-09-21       Impact factor: 1.972

9.  Serotonin receptors are involved in the spinal mediation of descending facilitation of surgical incision-induced increase of Fos-like immunoreactivity in rats.

Authors:  João Walter S Silveira; Quintino M Dias; Elaine A Del Bel; Wiliam A Prado
Journal:  Mol Pain       Date:  2010-03-23       Impact factor: 3.395

Review 10.  Serotonin in pain and analgesia: actions in the periphery.

Authors:  Claudia Sommer
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.